Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Clinical trial NCT00031629 · COMPLETED

Trial details

NCT number: NCT00031629
Sponsor: Gynecologic Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Uterine Corpus Sarcoma Uterine Corpus Leiomyosarcoma

Start date: 2005-01-01
Primary completion: 2007-07-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.